Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats

Effects of Monoamine Reuptake Inhibitors in Assays of Acute Pain-Stimulated and Pain-Depressed Behavior in Rats

(2013) Marisa B. Rosenberg et al.   JOURNAL OF PAIN

Expression and treatment of pain-related behavioral depression

(2013) S. Stevens Negus   LAB ANIMAL

The FAAH inhibitor URB597 efficiently reduces tyrosine hydroxylase expression through CB1- and FAAH-independent mechanisms

(2012) Barbara Bosier et al.   BRITISH JOURNAL OF PHARMACOLOGY

Effects of the Delta Opioid Receptor Agonist SNC80 on Pain-Related Depression of Intracranial Self-Stimulation (ICSS) in Rats

(2012) S. Stevens Negus et al.   JOURNAL OF PAIN

An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee

(2012) John P. Huggins et al.   PAIN

Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: Effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment

(2012) Josée Guindon et al.   PHARMACOLOGICAL RESEARCH

The Role of Endocannabinoids in Pain Modulation and the Therapeutic Potential of Inhibiting their Enzymatic Degradation

(2011) L. J. Alvarez-Jaimes et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Inactivation of Lipid Glyceryl Ester Metabolism in Human THP1 Monocytes/Macrophages by Activated Organophosphorus Insecticides: Role of Carboxylesterases 1 and 2

(2010) Shuqi Xie et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Role of Cannabinoids in the Treatment of Pain and (Painful) Spasticity

(2010) Matthias Karst et al.   DRUGS

Antagonism of ∆9-THC induced behavioral effects by rimonabant: Time course studies in rats

(2010) Torbjörn U.C. Järbe et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

An anatomical and temporal portrait of physiological substrates for fatty acid amide hydrolase

(2010) Jonathan Z. Long et al.   JOURNAL OF LIPID RESEARCH

Effects of kappa opioids in an assay of pain-depressed intracranial self-stimulation in rats

(2010) S. Stevens Negus et al.   PSYCHOPHARMACOLOGY

Targeting Fatty Acid Amide Hydrolase (FAAH) to Treat Pain and Inflammation

(2009) Joel E. Schlosburg et al.   AAPS Journal

URB597, an inhibitor of fatty acid amide hydrolase, reduces hyperalgesia in diabetic rats

(2009) Parisa Hasanein et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Synergy between Enzyme Inhibitors of Fatty Acid Amide Hydrolase and Cyclooxygenase in Visceral Nociception

(2009) P. S. Naidu et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: Further studies on pain-depressed behavior

(2009) Gail Pereira Do Carmo et al.   PAIN

Inhibition of fatty acid amide hydrolase produces PPAR-α-mediated analgesia in a rat model of inflammatory pain

(2008) D R Sagar et al.   BRITISH JOURNAL OF PHARMACOLOGY

The selective non-peptidic delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats

(2008) Gail Pereira Do Carmo et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action

(2007) C J Fowler   BRITISH JOURNAL OF PHARMACOLOGY